Neuland Laboratories (NSE:NEULANDLAB) Interest Expense : ₹-140 Mil (TTM As of Mar. 2024)

View and export this data going back to 2008. Start your Free Trial

What is Neuland Laboratories Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Neuland Laboratories's interest expense for the three months ended in Mar. 2024 was ₹ -36 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was ₹-140 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Neuland Laboratories's Operating Income for the three months ended in Mar. 2024 was ₹ 905 Mil. Neuland Laboratories's Interest Expense for the three months ended in Mar. 2024 was ₹ -36 Mil. Neuland Laboratories's Interest Coverage for the quarter that ended in Mar. 2024 was 25.06. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Neuland Laboratories Interest Expense Historical Data

The historical data trend for Neuland Laboratories's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neuland Laboratories Interest Expense Chart

Neuland Laboratories Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Interest Expense

Get a 7-Day Free Trial

-161.53

-128.01

-95.34

-130.67

-139.97

Neuland Laboratories Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Interest Expense	Get a 7-Day Free Trial															-42.89	-22.14	-44.33	-37.41	-36.09

Neuland Laboratories Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-140 Mil.

Neuland Laboratories (NSE:NEULANDLAB) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Neuland Laboratories's Interest Expense for the three months ended in Mar. 2024 was ₹-36 Mil. Its Operating Income for the three months ended in Mar. 2024 was ₹905 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was ₹541 Mil.

Neuland Laboratories's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Mar. 2024 )	/	Interest Expense (Q: Mar. 2024 )
	=	-1	*	904.54	/	-36.09
	=	25.06

The higher the ratio, the stronger the company's financial strength is.

Neuland Laboratories (NSE:NEULANDLAB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Neuland Laboratories Ltd (NSE:NEULANDLAB) » Definitions » Interest Expense

Traded in Other Exchanges

524558:India

Address

Road No. 82, Jubilee Hills, Plot No. 573A-III, Phoenix IVY Building, 11th Floor (5th Office Level), Hyderabad, TG, IND, 500033

Website

https://www.neulandlabs.com

Neuland Laboratories Ltd is a manufacturer of active pharmaceutical ingredients (APIs) and an end-to-end solution provider for the pharmaceutical industry's chemistry needs in Hyderabad. Geographically, it derives a majority of revenue from North America and also has a presence in India, Europe, and Rest of the world.

Neuland Laboratories (NSE:NEULANDLAB) Headlines

No Headlines